ABSTRACT
The objective was to determine the long-term effect of 3-nitrooxypropanol (3-NOP) on CH4 emission and milk production characteristics from dairy cows receiving 3-NOP in their diet for a full year, covering all lactation stages of the dairy cows. Sixty-four late-lactation Holstein Friesian cows (34% primiparous) were blocked in pairs, based on expected calving date, parity, and daily milk yield. The experiment started with an adaptation period of 1 week followed by a covariate period of 3 weeks in which all cows received the same basal diet and baseline measurements were performed. Directly after, cows within a block were randomly allocated to 1 of 2 dietary treatments: a diet containing on average 69.8 mg 3-NOP/kg DM (total ration level, corrected for intake of non-supplemented GreenFeed bait) and a diet containing a placebo. Forage composition as well as forage to concentrate ratio altered with lactation stage (i.e., dry period and early, mid, and late lactation). Diets were provided as a total mixed ration and additional bait was fed in GreenFeed units which were used for emission measurements. Supplementation of 3-NOP did not affect total dry matter intake (DMI), body weight or body condition score, but resulted in a 6.5% increase in the yields of energy-corrected milk and fat- and protein-corrected milk (FPCM). Furthermore, milk fat and protein as well as feed efficiency were increased upon 3-NOP supplementation. Overall, a reduction of 21%, 20%, and 27% was achieved for CH4 production (g/d), yield (g/kg DMI), and intensity (g/kg FPCM), respectively, upon 3-NOP supplementation. The CH4 mitigation potential of 3-NOP was affected by the lactation stage dependent diet to which 3-NOP was supplemented. On average, a 16%, 20%, 16%, and 26% reduction in CH4 yield (g/kg DMI) was achieved upon 3-NOP supplementation for the dry period, and early, mid, and late lactation diet, respectively. The CH4 mitigation potential of 3-NOP was affected by the length of 3-NOP supplementation within a lactation stage dependent diet and by variation in diet composition within a lactation stage dependent diet as a result of changes in grass and corn silage silos. In conclusion, 3-NOP reduced CH4 emission from cows receiving 3-NOP for a year, with a positive impact on production characteristics. The CH4 mitigation potential of 3-NOP was influenced by diet type, diet composition, and nutrition value, and the efficacy of 3-NOP appeared to decline over time but not continuously. Associated with changes in diet composition, increased efficacy of 3-NOP was observed at the start of the trial, at the start of a new lactation, and, importantly, at the end of the trial. These results suggests that diet composition has a large effect on the efficacy of 3-NOP, perhaps even larger than the week of supplementation after first introduction of 3-NOP. Further studies are needed to clarify the long-term effect of 3-NOP on CH4 emission and to further investigate the effect that variation in diet composition may have on the mitigation potential of 3-NOP.
ABSTRACT
Enteric methane (CH4) is the main source of greenhouse gas emissions from ruminants. The red seaweeds Asparagopsis taxiformis (AT) and Asparagopsis armata contain halogenated compounds, including bromoform (CHBr3), which may strongly decrease enteric CH4 emissions. Bromoform is known to have several toxicological effects in rats and mice and is quickly excreted by the animals. This study investigated the transfer of CHBr3 present in AT to milk, urine, feces, and animal tissue when incorporated in the diet of dairy cows. Twelve lactating Holstein-Friesian dairy cows were randomly assigned to three treatment groups, representing the target dose (low), 2× target dose (medium), and 5× target dose (high). The adaptation period lasted seven days, and subsequently cows were fed AT for 22 days maximally. The transfer of CHBr3 to the urine at days 1 and 10 (10-148 µg/L) was found with all treatments. On day 1, CHBr3 was detected in the milk of most cows in the low and medium treatment groups (9.1 and 11 µg/L, respectively), and detected in the milk of one cow in the high treatment group on day 9 (35 µg/L). Bromoform was not detected in milk and urine at day 17, nor at concentrations above the detection limit in feces and collected animal tissues. Two animals (low) were sacrificed, and their rumen wall showed abnormalities. Upon histological examination, signs of inflammation became visible. Animals regularly refused the feed or distinctively selected against AT. In conclusion, within the confines of the present experiment, CHBr3 does not accumulate in animal tissue, but can be excreted in urine and milk.
